IDO1 and melanoma: IDO inhibitor can slow the growth of subcutaneous Lewis lung cancer and B16 melanoma tumor graft, in which the tumor cells do not express IDO, but the formation of tumor induces the continuous increase of IDO production and exert its function on DCs in inflammatory tumor-draining lymph node (TDLN) (137).